Rapamycin enriches for CD4(+) CD25(+) CD27(+) Foxp3(+) regulatory T cells in ex vivo-expanded CD25-enriched products from healthy donors and patients with multiple sclerosis.

No abstract is available for this paper.

• Publication year

  2007

• Venue

  Cytotherapy

• Publication date

  Unknown publication date

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1080/14653240601145223PMID 17453966
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Rapamycin, and not cyclosporin A, preserves the highly suppressive CD27+ subset of human CD4+CD25+ regulatory T cells.

  2006cited by this paper
• Single-cell analysis of normal and FOXP3-mutant human T cells: FOXP3 expression without regulatory T cell development.

  2006cited by this paper
• Cutting Edge: Anti-CD25 Monoclonal Antibody Injection Results in the Functional Inactivation, Not Depletion, of CD4+CD25+ T Regulatory Cells1

  2006cited by this paper
• Rapamycin selectively expands CD4+CD25+FoxP3+ regulatory T cells.

  2005cited by this paper
• Autoreactive human peripheral blood CD8+ T cells with a regulatory phenotype and function

  2005cited by this paper
• Expression of FOXP3 mRNA is not confined to CD4+CD25+ T regulatory cells in humans.

  2005cited by this paper
• CD27/CFSE-Based Ex Vivo Selection of Highly Suppressive Alloantigen-Specific Human Regulatory T Cells1

  2005cited by this paper
• Analysis of FOXP3 protein expression in human CD4+CD25+ regulatory T cells at the single‐cell level

  2005cited by this paper
• Coexpression of CD25 and CD27 identifies FoxP3+ regulatory T cells in inflamed synovia

  2005cited by this paper
• Effects of Immunosuppressants on Induction of Regulatory Cells After Intratracheal Delivery of Alloantigen

  2005cited by this paper
• Immunology of multiple sclerosis.

  2005cited by this paper
• Differential Effect of Calcineurin Inhibitors, Anti-CD25 Antibodies and Rapamycin on the Induction of FOXP3 in Human T Cells

  2005cited by this paper
• Functional defect of regulatory CD4(+)CD25+ T cells in the thymus of patients with autoimmune myasthenia gravis.

  2005cited by this paper
• Everolimus and Basiliximab Permit Suppression by Human CD4+CD25+ Cells in vitro

  2005cited by this paper
• TCR stimulation with modified anti-CD3 mAb expands CD8+ T cell population and induces CD8+CD25+ Tregs.

  2005cited by this paper
• De novo generation of antigen-specific CD4+CD25+ regulatory T cells from human CD4+CD25- cells.

  2005cited by this paper
• FOCIS abstract supplement

  2005cited by this paper
• Acceleration of apoptosis in CD4+CD8+ thymocytes by rapamycin accompanied by increased CD4+CD25+ T cells in the periphery1

  2004cited by this paper
• Generation of Aspergillus- and CMV- specific T-cell responses using autologous fast DC.

  2004cited by this paper
• In Vitro–expanded Antigen-specific Regulatory T Cells Suppress Autoimmune Diabetes

  2004cited by this paper
• Large scale in vitro expansion of polyclonal human CD4+CD25high regulatory T cells

  2004cited by this paper
• Alloantigen specific CD8+CD28- FOXP3+ T suppressor cells induce ILT3+ ILT4+ tolerogenic endothelial cells, inhibiting alloreactivity.

  2004cited by this paper
• Loss of Functional Suppression by CD4+CD25+ Regulatory T Cells in Patients with Multiple Sclerosis

  2004cited by this paper
• Cord blood CD4(+)CD25(+)-derived T regulatory cell lines express FoxP3 protein and manifest potent suppressor function.

  2004cited by this paper
• CD4+CD25+ regulatory T cells control induction of autoimmune hemolytic anemia.

  2004cited by this paper
• In vitro-expanded human CD4(+)CD25(+) T-regulatory cells can markedly inhibit allogeneic dendritic cell-stimulated MLR cultures.

  2004cited by this paper
• Defective Suppressor Function of Human CD4+ CD25+ Regulatory T Cells in Autoimmune Polyglandular Syndrome Type II

  2004cited by this paper
• Cutting Edge: Cure of Colitis by CD4+CD25+ Regulatory T Cells1

  2003cited by this paper
• Induction of FoxP3 and acquisition of T regulatory activity by stimulated human CD4+CD25- T cells.

  2003cited by this paper
• Foxp3 programs the development and function of CD4+CD25+ regulatory T cells

  2003cited by this paper
• Supporting Online Material

  2003cited by this paper
• Immune dysregulation, polyendocrinopathy, enteropathy, and X-linked inheritance (IPEX), a syndrome of systemic autoimmunity caused by mutations of FOXP3, a critical regulator of T-cell homeostasis

  2003cited by this paper
• Effect of glatiramer acetate (Copaxone) on CD4+CD25high T regulatory cells and their IL-10 production in multiple sclerosis.

  2003cited by this paper
• Sirolimus: its discovery, biological properties, and mechanism of action.

  2003cited by this paper
• An essential role for Scurfin in CD4+CD25+ T regulatory cells

  2003cited by this paper
• Diversity of regulatory CD4+T cells controlling distinct organ-specific autoimmune diseases

  2003cited by this paper
• EncephalomyelitisExperimental Autoimmune System Inflammation During Active Immune Responses and Central Nervous Cells Suppress Antigen-Specific Autoreactive Regulatory T + CD25+ Cutting Edge: CD4

  2002cited by this paper
• CD25+ immunoregulatory T-cells of donor origin suppress alloreactivity after BMT.

  2002cited by this paper
• Immunological disturbances in the central nervous system linked to MRI findings in multiple sclerosis.

  2002cited by this paper
• Identification and Functional Characterization of Human Cd4+Cd25+ T Cells with Regulatory Properties Isolated from Peripheral Blood

  2001cited by this paper
• Differential cytokine requirements for regulation of autoimmune gastritis and colitis by CD4(+)CD25(+) T cells.

  2001cited by this paper
• Human Cd25+Cd4+ T Regulatory Cells Suppress Naive and Memory T Cell Proliferation and Can Be Expanded in Vitro without Loss of Function

  2001cited by this paper
• Ex Vivo Isolation and Characterization of Cd4+Cd25+ T Cells with Regulatory Properties from Human Blood

  2001cited by this paper
• Control of experimental inflammatory bowel disease by regulatory T cells.

  2000cited by this paper
• B7/CD28 costimulation is essential for the homeostasis of the CD4+CD25+ immunoregulatory T cells that control autoimmune diabetes.

  2000cited by this paper
• Immunopharmacology of rapamycin.

  1996cited by this paper
• Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases.

  1995cited by this paper
• Rapamycin blocks cell cycle progression of activated T cells prior to events characteristic of the middle to late G1 phase of the cycle

  1993cited by this paper
• Failure of rapamycin to block proliferation once resting cells have entered the cell cycle despite inactivation of p70 S6 kinase.

  1993cited by this paper
• Organ-specific autoimmune diseases induced in mice by elimination of T cell subset. I. Evidence for the active participation of T cells in natural self-tolerance; deficit of a T cell subset as a possible cause of autoimmune disease

  1985cited by this paper

• Enhancing the functionality of self-assembled immune signals using chemical crosslinks

  2023cites this paper
• Regulatory T cells induce transplant immune tolerance.

  2021cites this paper
• Rapamycin Alleviates the Symptoms of Multiple Sclerosis in Experimental Autoimmune Encephalomyelitis (EAE) Through Mediating the TAM-TLRs-SOCS Pathway

  2020cites this paper
• CD226 Attenuates Treg Proliferation via Akt and Erk Signaling in an EAE Model

  2020cites this paper
• Regulatory Cell Levels Decrease in People Infected With Schistosomamansoni on Effective Treatment

  2019cites this paper
• Metformin and Autoimmunity: A “New Deal” of an Old Drug

  2018cites this paper
• Review: A Novel Multiple Sclerosis Model Utilizing Cuprizone and Rapamycin

  2016cites this paper
• Identification, Isolation, and Functional Assay of Regulatory T Cells

  2016cites this paper
• The Role of Adenomatous Polyposis Coli in T cell biology: Development, Naïve T cell maintenance, and T cell Homeostatic Proliferation.

  2015influential citation
• Interplay between mTOR and STAT5 signaling modulates the balance between regulatory and effective T cells.

  2015cites this paper
• Influence of sirolimus-induced TGF-β secretion on mouse Treg cell proliferation.

  2015cites this paper
• Lymphocyte Activation Markers in Pediatric Kidney Transplant Recipients

  2015cites this paper
• The effects of rapamycin on regulatory T cells: its potential time-dependent role in inducing transplant tolerance.

  2014cites this paper
• In vitro generation of human FOXP3+ regulatory T cells

  2014cites this paper
• ИНФОРМАЦИОННАЯ ЗНАЧИМОСТЬ МОНИТОРИНГА ПОПУЛЯЦИЙ СD4+ Т-ЛИМФОЦИТОВ В ДИАГНОСТИКЕ И ПРОГНОЗИРОВАНИИ РЕАКЦИИ ОРГАНИЗМА НА ТРАНСПЛАНТАТ

  2014cites this paper
• Rapamycin combined with donor immature dendritic cells promotes liver allograft survival in association with CD4+CD25+Foxp3+ regulatory T cell expansion

  2012cites this paper
• The Effects of Immunosuppression on Regulatory CD4+CD25+ T Cells

  2012cites this paper
• The Evolving Role of mTOR Inhibition in Transplantation Tolerance

  2011cites this paper
• Regulatory T-cell as orchestra leader in immunosuppression process of multiple sclerosis

  2011cites this paper
• Pharmacologic expansion of donor-derived, naturally occurring CD4(+)Foxp3(+) regulatory T cells reduces acute graft-versus-host disease lethality without abrogating the graft-versus-leukemia effect in murine models.

  2011cites this paper
• Monitoring of CD4+CD25highIL-7Rαhigh activated T cells in kidney transplant recipients.

  2011cites this paper
• Monitoring of CD 4 CD 25 highIL-7 R high activated T Cells in Kidney Transplant Recipients

  2011cites this paper
• The evolving role of mTOR inhibition in transplantation tolerance.

  2011cites this paper
• The Evolving Role of mTOR Inhibition in Transplantation Tolerance

  2011cites this paper
• Connecting the mechanisms of T‐cell regulation: dendritic cells as the missing link

  2010cites this paper
• Allospecific Regulatory Effects of Sirolimus and Tacrolimus in the Human Mixed Lymphocyte Reaction

  2010cites this paper
• Novel mechanism of rapamycin in GVHD: increase in interstitial regulatory T cells

  2010cites this paper
• Regulatory T Cells in Many Flavors Control Asthma

  2010cites this paper
• Animal models of multiple sclerosis—Potentials and limitations

  2010cites this paper
• Isolation und in vitro Expansion von humanen CD4 + CD25 high regulatorischen T Zellen und ihre immunregulatorischen Effekte auf die Alloreaktivität

  2010cites this paper
• Living donor kidney transplantation without transmission of multiple sclerosis after 10 years.

  2009cites this paper
• Cellular adoptive immunotherapy after autologous and allogeneic hematopoietic stem cell transplantation.

  2009cites this paper
• Rapamycin, unlike cyclosporine A, enhances suppressive functions of in vitro-induced CD4+CD25+ Tregs.

  2009cites this paper
• Selective expression of latency-associated peptide (LAP) and IL-1 receptor type I/II (CD121a/CD121b) on activated human FOXP3+ regulatory T cells allows for their purification from expansion cultures.

  2009cites this paper
• Ex vivo expansion of CD4+CD25+ T regulatory cells for immunosuppressive therapy

  2009cites this paper
• Immunoregulatory functions of mTOR inhibition

  2009cites this paper
• Short report: Childhood coinfections with Plasmodium falciparum and Schistosoma mansoni result in lower percentages of activated T cells and T regulatory memory cells than schistosomiasis only.

  2009cites this paper
• Regulatory T cells and their role in rheumatic diseases: a potential target for novel therapeutic development

  2008cites this paper
• Mapping similarities in mTOR pathway perturbations in mouse lupus nephritis models and human lupus nephritis

  2008cites this paper
• Differences in regulatory T cells between Churg-Strauss syndrome and chronic eosinophilic pneumonia with asthma.

  2008cites this paper
• Impact of Immunosuppressive Drugs on CD4+CD25+FOXP3+ Regulatory T Cells: Does In Vitro Evidence Translate to the Clinical Setting?

  2008cites this paper
• Mechanisms of Disease: the evolving understanding of liver allograft rejection

  2008cites this paper
• De novo induction of antigen‐specific CD4+CD25+Foxp3+ regulatory T cells in vivo following systemic antigen administration accompanied by blockade of mTOR

  2008cites this paper
• Novel therapeutic strategies for multiple sclerosis — a multifaceted adversary

  2008cites this paper
• Animal models of multiple sclerosis for the development and validation of novel therapies – potential and limitations

  2008cites this paper
• Clinical‐grade preparation of human natural regulatory T‐cells encoding the thymidine kinase suicide gene as a safety gene

  2008cites this paper
• T regulatory cell levels decrease in people infected with Schistosoma mansoni on effective treatment.

  2007cites this paper